The Cancer Letter

Inside information on cancer research and drug development

Vol.
27
No.
8
August 27, 2004Aug 27, 2004
Free
DOWNLOAD THE PDF

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

Exercise Improves Function, Symptoms Of Cancer Survivors, AHRQ Report Finds

Guideline Adherence Improves Early Breast Cancer Survival

Chemosensitivity, Resistance Assays Not Ready For Clinic, ASCO Tech Assessment Says

FDA Approves Taxotere For Node+ Breast Cancer

FDA Approves Lilly’s Alimta For Metastatic NSCLC

Reduced Risk of Metastasis When Screening Finds Cancer

Ellence Has Lower Risk Of Heart Damage, Study Finds

Modality Combo Decreases Prostate Cancer Recurrence

Hormonal Therapy Improves Prostate Cancer Survival

Study Suggests Surveillance Colonoscopies Overperformed

Login

Looking for IP Login?